Abcam vs MindImmune

Abcam vs MindImmune, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abcam is on 61/100 and MindImmune on 53/100.

Abcam logo
AbcamGlobal supplier of life science research tools, including antibodies, reagents, and assays.
Try Abcam
MindImmune logo
MindImmuneDeveloping AI-powered diagnostics for neurodegenerative diseases.
Try MindImmune

Where each one leads

Abcam

  • our overall score: 61/100 against 53/100
  • domain rating: 72/100 against 23/100
  • funding raised: $257M against $35.0M

MindImmune

  • agent readiness: 33/100 against 22/100

At a glance

MeasureAbcamMindImmune
What it isGlobal supplier of life science research tools, including antibodies, reagents, and assays.Developing AI-powered diagnostics for neurodegenerative diseases.
CategoryBiotechnology, Life Sciences, Discovery Tools, AntibodiesBiotechnology, Artificial Intelligence, Healthcare, Diagnostics
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformSoftware
Founded19982021
HeadquartersCambridge, United KingdomParis, France
StatusActiveActive

Size, funding and growth

MeasureAbcamMindImmune
Total funding$257M$35.0M
Latest roundSeries DStrategic Investment
ValuationNot published$1.1B

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAbcamMindImmune
StartupHub scoreOur 0-100 rating61/10053/100
Traction40/10038/100
Team70/10060/100
Community15/100Not published
Search visibility16/1003/100
Quality78/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (22/100)F (33/100)
Domain ratingLink authority, 0-10072/10023/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAbcamMindImmune
CDNNot detectedCloudflare
CMSNot detectedWebflow

Abcam vs MindImmune: common questions

Which is better, Abcam or MindImmune?

On our 0-100 score Abcam rates higher (61/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Abcam and MindImmune compare on the numbers?

Abcam leads on our overall score (61/100 against 53/100), domain rating (72/100 against 23/100), funding raised ($257M against $35.0M). MindImmune leads on agent readiness (33/100 against 22/100).

Read the full Abcam review and pricing or the MindImmune review and pricing. You can also browse other Abcam alternatives we track.